Previous Pause Next
Home >> News Center >>
White-nose Syndrome Death in Bats: First Prevention Proposed by Ecologists PDF Print E-mail
User Rating :  / 0
Tuesday, 10 March 2009 07:46

White-nose syndrome (WNS) is a poorly understood condition that, in the two years since its discovery, has spread to at least seven northeastern states and killed as many as half a million bats. Now researchers have suggested the first step toward a measure that may help save the affected bats: providing localized heat sources to the hibernating animals.

"We have no idea why it's spreading so rapidly," says Justin Boyles, a graduate student in biology at Indiana State University and the first author of the paper, published the week of March 4 in Frontiers in Ecology and the Environment e-View.

The syndrome has baffled scientists since its discovery in the winter of 2006 in upstate New York, where hibernating bats were found with a mysterious white fungus growing on their faces and wing membranes. Hundreds of emaciated bats were found dead in and around their caves, suggesting that they had starved to death during their hibernating months, and affected populations commonly suffer 75 to 100 percent mortality.

The origins of WNS are virtually unknown – scientists just identified the fungus species last month. But they are still mystified by its relationship to such unprecedented bat mortality.

Boyles and his coauthor Craig Willis of the University of Winnipeg tested the idea, suspected by many in the bat research community, that the fungus causes bats to spend more time out of hibernation during the winter. Mammals must rouse from hibernation periodically, but doing so too often or for long periods of time is energetically costly. When they rouse, the bats must use body energy to keep warm; spending too much time out of hibernation may deplete their fat reserves and cause them to starve to death, say the authors.

Because of the rapid spread of the fungus and the fact that field experiments can take months to years to complete, Boyles and Willis instead created a mathematical simulation to test the idea that the fungus is causing bats to spend more time out of hibernation. Their model took into account the patterns of arousal, body mass and percentage body fat of a particular species, called little brown bats, which are affected by the fungus.

The simulation showed that the patterns and proportion – about 82 percent – of bat mortality observed in affected populations in the wild are consistent with a large increase in the amount of time spent out of hibernation during the winter months. Their results, they say, provide evidence that the fungus is likely affecting bat hibernation patterns.

The researchers then took the simulation one step further. They reasoned that one way to help affected bats save their energy reserves and survive the winter is to provide them with a heat source, so they don't have to create as much body heat when they rouse. Bats often fly to the warmest parts of their cave during bouts of arousal.

"They already do this in the wild," Boyles says. "What we're suggesting is accentuating that behavior."

When the authors altered the simulation to include localized heat sources the bats could gather in during arousals, the model showed that mortality levels dropped to as little as 8 percent.

These results could be used in the short-term to prevent bat populations from crashing below sustainable levels, the authors say. They are currently developing a system, using wooden boxes and heating coils, to create warm pockets in bat caves. The plan holds no guarantees: the overall temperature in the cave needs to stay cold enough so that bats can still lower their body temperatures during hibernation. But the researchers are optimistic.

"By insulating the bat boxes and carefully selecting where we will place them, we think we can solve this issue," says Willis.

Further, saving afflicted animals may not be sustainable in the long term, say the authors. If WNS is transmitted in spring and summer by surviving bats, saving its carriers will also save the disease, they write. At present, the search for a remedy for this mysterious fungus continues to stymie scientists.

"I can't even guess what the cure or the solution to this is going to be," says Boyles. "This isn't a cure. We're going for a stopgap."


Adapted from materials provided by Ecological Society of America, via EurekAlert!, a service of AAAS.
 
FairExcellent 

Add comment  |   Add to my library  |  Forward this article

login to leave comment

Collaboration, Projects, & Consortia

Indiana Clinical and Translational Science Institute HUB: A model for collaboration

TGen, Karmanos Lead $6M Melanoma Project

Sanford-Burnham Medical Research Institute and Pfizer Collaborate to Speed Drug Discovery

e2v aerospace and defense and Maxim Announce an Agreement to Extend the Product Life of Maxim Ceramic ICs

Syntaxin and Ipsen Ally to Develop Botulinum Toxin Therapeutics

BioAmber and LANXESS Partner for Renewable, Phthalate-free Plasticizers

Corgenix Partners with AXA Diagnostics on SkyLAB 752™ Automated Testing Platform

GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells

EMD Serono and Fast Forward Commit $3 Million for Multiple Sclerosis

VisionGate Begins Collaborations to Evaluate 3-D Cell Analysis Test for Lung Cancer Screening

>> More in: Collaboration, Projects and Consortia

Featured Experts

Featured Laboratories

Grant & Funding Opportunities

NHGRI Unveils New-Look Genome Sequencing Program; Plans $416M in Funding

NYU to Study Genetics of Obesity-Related Cancers

Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing

Venture Firms Pump $18M into Fledgling Arteaus Therapeutics

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Tetraphase Awarded Initial $6M by NIAID to Develop Antibiotic Against Biothreats

Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology

Salk Institute for Biological Studies to Accelerate Brain Research With $4.5 Million National Institutes of Health (NIH) Grant

Arsanis Wins €1.2M for Research on Antibody Against Hospital-Acquired Infections

SAMHSA Awards Approximately $1.3 Million To Help Communities Offer Expanded HIV Testing, Counseling And Referral For Care

>> More in: Grant & Funding Opportunities

Appointments

Sanofi (France) Taps David Meeker as New CEO of Genzyme Corporation

Drug Information Association Appoints Kaushik Desai as DIA India Director

Sentrx Announces Resignation of Charles T. Saldarini As CEO

EKR Therapeutics Announces Senior Management Change

Amgen Appoints Robert A. Bradway to the Company's Board of Directors

Anavex Life Sciences Corp. Appoints Dr. George Tidmarsh as Executive Director

Isis Biopolymer Appoints New President and CEO

RedHill Biopharma Appoints Key Opinion Leader Professor David Y. Graham from Baylor College of Medicine, Houston, Texas, as Lead Investigator for the US Pivotal Clinical Trial with RedHill's Crohn’s Drug – RHB-104

Apceth is Extending its Top Management: Prof. Ralf Huss Moves from Roche (RHHBY) to the Biotechnology Company apceth

BioIndustry Association Board Appointments

>> More in: Appointments

Recognitions

Journal names discovery that HIV treatment can prevent spread 'breakthrough of the year'

Abbott Laboratories's Absorb(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

Chris Henney Receives 2011 Hall of Fame Award at Annual Biotech CEO Meeting at Laguna Beach

Scripps Florida Scientist Awarded $2.2 Million Grant To Study Hepatitis C

SAMHSA Awards Up To $25 Million To Expand Use Of Health Information Technology

Ablitech, Inc. Awarded $2 Million

The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine

SAMHSA Awards Grant To UCLA For Substance Abuse Prevention In Iraq

KGI Professor Awarded Patent For Stem-Cell Therapy Aiding Heart-attack Patients

Nobel Prize for chemistry 2011 goes to Israeli scientist Daniel Shechtman

>> More in: Recognitions